4BA A randomized phase III study comparing epirubicin, docetaxel, and capecitabine (EDC) to epirubicin and docetaxel (ED) as neoadjuvant treatment for early breast cancer – first results of the Austrian Breast and Colorectal Cancer Study Group-Trial 24 (ABCSG-24)
| Autor: | Steger, G.G., Greil, R., Jakesz, R., Lang, A., Mlineritsch, B., Melbinger-Zeinitzer, E., Marth, C., Samonigg, H., Kubista, E., Gnant, M. |
|---|---|
| Zdroj: | In EJC Supplements 2009 7(3):3-3 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect